Tokyo Electric Power Company has suspended the first attempt to extract fuel debris from within the primary containment vessel of unit 2 at the damaged Fukushima ...

(RTTNews) - Merck & Co., Inc. (MRK) and Daiichi Sankyo (DSKYF.PK) announced that an interim analysis of the dose-optimization phase of the ongoing IDeate-Lung01 Phase 2 trial shows ifinatamab ...

On Wednesday, Jefferies, a global investment banking firm, updated its outlook on shares of Daiichi Sankyo Company, Limited (4568:JP) (OTC: DSNKY), raising the price target to JPY7,600 from JPY6,600.

Data at WCLC and ESMO showcasing Daiichi Sankyo’s progress towards its goal of creating new standards of care for patients with cancer will include six late-breaking presentations, including two ...

That’s according to Daiichi Sankyo’s UK managing director Manuel Reiberg, whose goal is to make sure the firm is a “responsible pharma company”. Reiberg says this approach rests on two ...

Daiichi Sankyo has identified inequalities in cardiovascular disease treatment and outcomes, finding that women in Europe are less likely than men to receive lipid-lowering therapies and achieve ...

On the same day at the Kallang Football Hub, Ng and BG Tampines Rovers’ Japanese midfielder Kyoga Nakamura, both 28, trained with the Lions for the first time in a move that the Football ...

NHK has learned that workers failed to check the alignment of pipes to be used for the test retrieval of nuclear fuel debris from a reactor at the damaged Fukushima Daiichi nuclear plant.

MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced its reinforced commitment to addressing key unmet needs and barriers in cardiovascular (CV) care ...

2,3 Patient comorbidities and frailty may unnecessarily affect CVD management. 4,5,6 Daiichi Sankyo remains committed to its promise to continue expanding medical knowledge to support better CV ...

Esaxerenone is under clinical development by Daiichi Sankyo and currently in Phase II for Diabetic Hypertension. According to GlobalData, Phase II drugs for Diabetic Hypertension does not have ...

Pexidartinib hydrochloride is under clinical development by Daiichi Sankyo and currently in Phase II for Sarcomas. According to GlobalData, Phase II drugs for Sarcomas have a 27% phase transition ...